Join
Live feed
·
PRReleasevia Quantisnow
Kyntra Bio Inc. logo

Kyntra Bio Presents New Roxadustat Data on Improvements in Transfusion Independence Regardless of Ring Sideroblast Status in Patients with Anemia due to Lower-Risk Myelodysplastic Syndromes

ByQuantisnow·Wall Street's wire, on your screen.
KYNB· Kyntra Bio Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KYNB (Kyntra Bio Inc.) and more on Quantisnow.